{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:22:20Z","timestamp":1794871340975,"version":"4.9.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005311","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T05:00:31Z","timestamp":1736744431000},"page":"569-579","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance"],"prefix":"10.1097","volume":"109","author":[{"given":"Helen","family":"Stark","sequence":"first","affiliation":[{"name":"Translational Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan Yao","family":"Ho","sequence":"additional","affiliation":[{"name":"Translational Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK."},{"name":"Department of Renal Medicine, Singapore General Hospital, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Cross","sequence":"additional","affiliation":[{"name":"Translational Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Alessandrini","sequence":"additional","affiliation":[{"name":"Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bertaina","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brennan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Busque","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Abdominal Transplantation, Stanford University School of Medicine, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Demetris","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Transplantation, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Devey","sequence":"additional","affiliation":[{"name":"Quell Therapeutics, Translation and Innovation Hub, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Fruhwirth","sequence":"additional","affiliation":[{"name":"Imaging Therapies and Cancer Group, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim","family":"Fuchs","sequence":"additional","affiliation":[{"name":"ImmunoFree Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Friend","sequence":"additional","affiliation":[{"name":"Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Geissler","sequence":"additional","affiliation":[{"name":"Division of Experimental Surgery, Department of Surgery, University Hospital Regensburg, Regensburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Guillonneau","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, INSERM, Center for Research in Transplantation and Translational Immunology, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Hester","sequence":"additional","affiliation":[{"name":"Translational Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Isaacs","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK."},{"name":"Musculoskeletal Unit and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Jaeckel","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Center, Massachusetts General Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Lakkis","sequence":"additional","affiliation":[{"name":"Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Leventhal","sequence":"additional","affiliation":[{"name":"Comprehensive Transplant Center at Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Levings","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Peter Gorer Department of Immunobiology, School of Immunology and Microbial Science, King\u2019s College London, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Martinez-Llordella","sequence":"additional","affiliation":[{"name":"Quell Therapeutics, Translation and Innovation Hub, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mathew","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Microbiology-Immunology, Comprehensive Transplant Center, Northwestern University, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Moreau","sequence":"additional","affiliation":[{"name":"INSERM, Nantes Universit\u00e9, CHU Nantes, Center for Research in Transplantation and Translational Immunology, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Reinke","sequence":"additional","affiliation":[{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin Center for Advanced Therapies (BeCAT), Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo V.","family":"Riella","sequence":"additional","affiliation":[{"name":"Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA."},{"name":"Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sachs","sequence":"additional","affiliation":[{"name":"Department of Surgery, Massachusetts General Hospital, Harvard University, Boston, MA."},{"name":"Medical School, Harvard University, Boston, MA."},{"name":"Columbia Center of Translational Immunology, Columbia University Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Sanchez","family":"Fueyo","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, King\u2019s College Hospital, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Schreeb","sequence":"additional","affiliation":[{"name":"Sangamo Therapeutics, Gloucestershire, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Sykes","sequence":"additional","affiliation":[{"name":"Columbia Center for Translational Immunology, Departments of Medicine, Surgery, and Microbiology and Immunology, Columbia University, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Diabetes Center, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Thomson","sequence":"additional","affiliation":[{"name":"Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Tree","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, School of Immunology and Microbial Sciences, King\u2019s College London, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Trzonkowski","sequence":"additional","affiliation":[{"name":"Medical University of Gdansk, Department of Medical Immunology, Gdansk, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Uchida","sequence":"additional","affiliation":[{"name":"Juntendo University Center for Immunotherapy and Diagnosis, Juntendo University Graduate School of Medicine, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Veale","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Weiner","sequence":"additional","affiliation":[{"name":"Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wekerle","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Issa","sequence":"additional","affiliation":[{"name":"Translational Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"R1-20250325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ajt.15533","article-title":"Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro.","volume":"20","author":"Podest\u00e0","year":"2020","journal-title":"Am J Transplant"},{"key":"R2-20250325","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/ajt.14251","article-title":"Origin of enriched regulatory T cells in patients receiving combined kidney-bone marrow transplantation to induce transplantation tolerance.","volume":"17","author":"Sprangers","year":"2017","journal-title":"Am J Transplant"},{"key":"R3-20250325","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/ajt.12731","article-title":"Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.","volume":"14","author":"Kawai","year":"2014","journal-title":"Am J Transplant"},{"key":"R4-20250325","doi-asserted-by":"crossref","first-page":"272ra10","DOI":"10.1126\/scitranslmed.3010760","article-title":"Tracking donor-reactive T cells: evidence for clonal deletion in tolerant kidney transplant patients.","volume":"7","author":"Morris","year":"2015","journal-title":"Sci Transl Med"},{"key":"R5-20250325","doi-asserted-by":"crossref","first-page":"e124086","DOI":"10.1172\/jci.insight.124086","article-title":"Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.","volume":"3","author":"Savage","year":"2018","journal-title":"JCI Insight"},{"key":"R6-20250325","doi-asserted-by":"crossref","first-page":"eaax8863","DOI":"10.1126\/scitranslmed.aax8863","article-title":"Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.","volume":"12","author":"Busque","year":"2020","journal-title":"Sci Transl Med"},{"key":"R7-20250325","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa2117028","article-title":"Sequential stem cell\u2013kidney transplantation in Schimke immuno-osseous dysplasia.","volume":"386","author":"Bertaina","year":"2022","journal-title":"N Engl J Med"},{"key":"R8-20250325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2024.1377535","article-title":"HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation.","volume":"15","author":"Senev","year":"2024","journal-title":"Front Immunol"},{"key":"R9-20250325","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"key":"R10-20250325","first-page":"1","article-title":"A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex001).","volume":"7","author":"Oberbauer","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R11-20250325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ajt.2022.09.002","article-title":"Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy.","volume":"23","author":"Muckenhuber","year":"2023","journal-title":"Am J Transplant"},{"key":"R12-20250325","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/ajt.16395","article-title":"Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients.","volume":"21","author":"Harden","year":"2021","journal-title":"Am J Transplant"},{"key":"R13-20250325","doi-asserted-by":"crossref","first-page":"e061864","DOI":"10.1136\/bmjopen-2022-061864","article-title":"Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.","volume":"12","author":"Brook","year":"2022","journal-title":"BMJ Open"},{"key":"R14-20250325","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials.","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"R15-20250325","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/TP.0000000000005065","article-title":"Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation.","volume":"108","author":"Brook","year":"2024","journal-title":"Transplantation"},{"key":"R16-20250325","doi-asserted-by":"crossref","first-page":"e0156535","DOI":"10.1371\/journal.pone.0156535","article-title":"Immunoregulatory effects of everolimus on in vitro alloimmune responses.","volume":"11","author":"Levitsky","year":"2016","journal-title":"PLoS One"},{"key":"R17-20250325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase i clinical trial with ex vivo expanded recipient regulatory t cells in living donor kidney transplants.","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep"},{"key":"R18-20250325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-19621-6","article-title":"Generation and characterization of alloantigen-specific regulatory T cells for clinical transplant tolerance.","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep"},{"key":"R19-20250325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-023-03157-7","article-title":"Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial.","volume":"24","author":"Dudreuilh","year":"2023","journal-title":"BMC Nephrol"},{"key":"R20-20250325","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/eji.202048949","article-title":"Isolation and expansion of thymus-derived regulatory T cells for use in pediatric heart transplant patients.","volume":"51","author":"Romano","year":"2021","journal-title":"Eur J Immunol"},{"key":"R21-20250325","doi-asserted-by":"crossref","first-page":"m3734","DOI":"10.1136\/bmj.m3734","article-title":"Regulatory T cells for minimising immune suppression in kidney transplantation: Phase I\/IIa clinical trial.","volume":"371","author":"Roemhild","year":"2020","journal-title":"The BMJ"},{"key":"R22-20250325","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.ymthe.2022.02.025","article-title":"Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD.","volume":"30","author":"Landwehr-Kenzel","year":"2022","journal-title":"Mol Ther"},{"key":"R23-20250325","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3389\/fimmu.2017.02014","article-title":"Ex vivo expanded human non-cytotoxic CD8+CD45RClow\/\u2212 Tregs efficiently delay skin graft rejection and GVHD in humanized mice.","volume":"8","author":"B\u00e9zie","year":"2018","journal-title":"Front Immunol"},{"key":"R24-20250325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.adf4287","article-title":"Donor-derived regulatory dendritic cell infusion modulates effector CD8+ T cell and NK cell responses after liver transplantation.","volume":"15","author":"Tran","year":"2023","journal-title":"Sci Transl Med"},{"key":"R25-20250325","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.kint.2022.08.037","article-title":"A phase I\/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.","volume":"103","author":"Moreau","year":"2023","journal-title":"Kidney Int"},{"key":"R26-20250325","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.31036","article-title":"Immunosuppression withdrawal in liver transplant recipients on sirolimus.","volume":"72","author":"Levitsky","year":"2020","journal-title":"Hepatology"},{"key":"R27-20250325","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hep.28681","article-title":"Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R conclusion-operationally tolerant pediatric liver transplant recipients maintain generally stable allograft histology in sp.","volume":"65","author":"Feng","year":"2017","journal-title":"Hepatology"},{"key":"R28-20250325","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ajt.15205","article-title":"Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.","volume":"19","author":"Shaked","year":"2019","journal-title":"Am J Transplant"},{"key":"R29-20250325","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.26426","article-title":"Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.","volume":"58","author":"Ben\u00edtez","year":"2013","journal-title":"Hepatology"},{"key":"R30-20250325","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.humimm.2017.10.007","article-title":"Tolerance in clinical liver transplantation.","volume":"79","author":"Levitsky","year":"2018","journal-title":"Hum Immunol"},{"key":"R31-20250325","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/ajt.15953","article-title":"Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation.","volume":"20","author":"Levitsky","year":"2020","journal-title":"Am J Transplant"},{"key":"R32-20250325","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajt.16835","article-title":"Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients.","volume":"22","author":"Levitsky","year":"2022","journal-title":"Am J Transplant"},{"key":"R33-20250325","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1172\/JCI59411","article-title":"Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation.","volume":"122","author":"Bohne","year":"2012","journal-title":"J Clin Invest"},{"key":"R34-20250325","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.32666","article-title":"Next-generation pathology detection of T cell-antigen-presenting cell immune synapses in human liver allografts.","volume":"77","author":"Wood-Trageser","year":"2023","journal-title":"Hepatology"},{"key":"R35-20250325","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/ajt.16880","article-title":"Novel intragraft regulatory lymphoid structures in kidney allograft tolerance.","volume":"22","author":"Rosales","year":"2022","journal-title":"Am J Transplant"},{"key":"R36-20250325","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ajt.2023.05.036","article-title":"Intragraft B cell differentiation during the development of tolerance to kidney allografts is associated with a regulatory B cell signature revealed by single cell transcriptomics.","volume":"23","author":"Guinn","year":"2023","journal-title":"Am J Transplant"},{"key":"R37-20250325","doi-asserted-by":"crossref","first-page":"e179709","DOI":"10.1172\/JCI179709","article-title":"Dysfunction of infiltrating cytotoxic CD8 + T cells within the graft promotes murine kidney allotransplant tolerance.","volume":"134","author":"Yokose","year":"2024","journal-title":"J Clin Investig"},{"key":"R38-20250325","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.0105-2896.2006.00406.x","article-title":"Infectious tolerance and the long-term acceptance of transplanted tissue.","volume":"212","author":"Waldmann","year":"2006","journal-title":"Immunol Rev"},{"key":"R39-20250325","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00125-013-3004-z","article-title":"Implanted islets in the anterior chamber of the eye are prone to autoimmune attack in a mouse model of diabetes.","volume":"56","author":"Mojibian","year":"2013","journal-title":"Diabetologia"},{"key":"R40-20250325","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.ymthe.2020.03.016","article-title":"Non-invasive reporter gene imaging of cell therapies, including T cells and stem cells.","volume":"28","author":"Ashmore-Harris","year":"2020","journal-title":"Mol Ther"},{"key":"R41-20250325","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.omtm.2020.12.003","article-title":"Spatiotemporal in vivo tracking of polyclonal human regulatory T cells (Tregs) reveals a role for innate immune cells in Treg transplant recruitment.","volume":"20","author":"Jacob","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R42-20250325","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/eji.202048934","article-title":"Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive.","volume":"51","author":"Mohseni","year":"2021","journal-title":"Eur J Immunol"},{"key":"R43-20250325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-1090-7","article-title":"Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.","volume":"14","author":"Marek-Trzonkowska","year":"2016","journal-title":"J Transl Med"},{"key":"R44-20250325","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/dom.14723","article-title":"Combined therapy with CD4+CD25highCD127\u2212 T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I\/II trial.","volume":"24","author":"Zieli\u0144ski","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"R45-20250325","doi-asserted-by":"crossref","first-page":"111919","DOI":"10.1016\/j.intimp.2024.111919","article-title":"PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration.","volume":"132","author":"Zieli\u0144ski","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R46-20250325","doi-asserted-by":"crossref","first-page":"102298","DOI":"10.1016\/j.jaut.2019.06.009","article-title":"Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study.","volume":"105","author":"Baker","year":"2019","journal-title":"J Autoimmun"},{"key":"R47-20250325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-45213-2","article-title":"Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission.","volume":"15","author":"Baker","year":"2024","journal-title":"Nat Commun"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:59:11Z","timestamp":1743148751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005311","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}